Aquestive Therapeutics
Price & Volume
Stats
See moreOpen | $3.49 |
Previous Close | $3.52 |
Day Range | $3.37-$3.52 |
52W Range | $2.12-$7.55 |
Market Cap | $429.4M |
Shares Short | 24M |
Financials
See moreRevenue (12 Mos) | $43.3M |
Revenue Growth (YoY) | -5.4% |
Gross Profit (12 Mos) | $26.1M |
Diluted EPS | -$0.70 |
News
See moreYahoo Finance • 2 months ago
Jim Cramer on Aquestive Therapeutics: “I Think It’s a Very Interesting Spec”
Yahoo Finance • 3 months ago
Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET
Yahoo Finance • 3 months ago
Sector Update: Health Care Stocks Advance Late Afternoon
Yahoo Finance • 3 months ago
Aquestive Therapeutics Broadens Patent Estate for Anaphylm™
About
CEO | Mr. Daniel Barber |
Address | 30 Technology Drive, Warren, NJ, United States, 07059 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 142 |
